Age, tumour size, axillary lymph node status (nodal status), estrogen receptor (ER), progesterone receptor (PgR), histological grade and HER2, are widely accepted factors for the assessment of the prognosis and adjuvant treatment decision-making in breast cancer. Here, ERBB2 is linked to neoplasm.